ArticleAMB Express2025
Control of avocado anthracnose by carposphere-associated Kosakonia cowanii VG1 for agricultural applications.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In silico structural and functional characterisation of two hypothetical proteins from the plant‑associated bacterium Kosakonia cowanii F52.Genomics & informatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Avocado anthracnose, a devastating fungal disease caused by Colletotrichum gloeosporioides and Colletotrichum acutatum, represents the most significant postharvest challenge for avocado production. This study evaluates the biocontrol potential of bacterial strains isolated from different niches within the avocado ecosystem, including fruits, roots, trunks and nectar. Among these isolates, the bacterium Kosakonia cowanii VG1, isolated from avocado carposphere, demonstrated the highest in vitro antagonistic activity, inhibiting mycelial growth and spore germination of both Colletrotrichum species by 70% and 65%, respectively. In vivo experiments with K. cowanii VG1 reduced disease severity by 60% in avocado fruits compared to untreated controls. Genomic analysis of K. cowanii VG1 revealed the absence of virulence factors, ensuring safety for human health. Additionally, fermentation analysis demonstrated that K. cowanii VG1 can be efficiently cultured at large scales. Additionally, a techno-economic evaluation showed that its production costs are competitive, ranging from $0.08-$0.15 per dose. These findings highlight the potential of K. cowanii VG1 as a promising, safe, and cost-effective biocontrol agent for managing avocado anthracnose, offering a sustainable alternative to synthetic fungicides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.